ClinicalTrials.Veeva

Menu

Human Selenoprotein P Concentration With Glucose Tolerance Status

K

Korea University

Status

Completed

Conditions

SEPP1 Levels in Differnet Glucose Tolerance Status

Study type

Observational

Funder types

Other

Identifiers

NCT01258426
SEPP1(DM)

Details and patient eligibility

About

Recently, seslenium(Se) has known as important regulator in metabolic status, lipid profile, atherosclerosis progression. SEPP1(selenoprotein P1)is a secreted protein from mainly liver. This protein is used as an index of selenium nutritional status. The association between the concentration of SEPP1(selenoprotein P1) in normal glucose tolerance,impaired glucose tolerance, type 2 diabetes is still a matter of debate. This cross sectional study will evaluate whether glucose status is matter in SEPP1 level.

Sex

All

Ages

20 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 20-80 years old
  • Not severe medical condition

Exclusion criteria

  • metformin, insulin using type 2 diabetes

Trial design

0 participants in 1 patient group

Normal, IGT, T2DM

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems